Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3870
Source ID: NCT02064881
Associated Drug: Metformin Glycinate
Title: Efficacy Study of Metformin Glycinate on Postprandial Lipemia
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Metformin glycinate|DRUG: Metformin Hydrochloride
Outcome Measures: Primary: Change in postprandial lipemia at 4 months, baseline, 4 months | Secondary: Change in oxidized LDL at 4 months, baseline, 4 months|Change in FGF-21 levels at 4 months, baseline, 4 months|Change in A1C at 4 months, baseline, 4 months|Change in alanine aminotransferase at 4 months, baseline, 4 months|Change in uric acid at 4 months, baseline, 4 months|Number of Participants with Serious and Non-Serious Adverse Events, up to 4 months
Sponsor/Collaborators: Sponsor: Laboratorios Silanes S.A. de C.V. | Collaborators: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2|PHASE3
Enrollment: 72
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2015-10
Completion Date: 2020-08
Results First Posted:
Last Update Posted: 2018-01-30
Locations: Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, México, Distrito Federal, 14000, Mexico
URL: https://clinicaltrials.gov/show/NCT02064881